Background/Aims: The alkylphospholipid perifosine is used for the treatment of malignancy. The substance is effective by triggering suicidal tumor cell death or apoptosis. Side effects of perifosine include anemia. At least in theory, perifosine-induced anemia could result from stimulation of suicidal erythrocyte death or eryptosis. Hallmarks of eryptosis are cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. Cellular mechanisms participating in the orchestration of eryptosis include increase of cytosolic Ca 2+ activity ([Ca 2+ ] i ), oxidative stress, increase of ceramide abundance, as well as activation of staurosporine sensitive protein kinase C and/or of SB203580 sensitive p38 kinase. The present study explored, whether perifosine induces eryptosis and, if so, whether its effect involves and/or requires Ca 2+ entry, oxidative stress, ceramide and kinase activation. Methods: Flow cytometry was employed to quantify phosphatidylserine exposure at the cell surface from annexin-V-binding, cell volume from forward scatter, [Ca 2+ ] i from Fluo3-fluorescence, reactive oxygen species (ROS) abundance from DCFDA dependent fluorescence, and ceramide abundance utilizing specific antibodies. Hemolysis was estimated from hemoglobin concentration in the supernatant. Results: A 24 hours exposure of human erythrocytes to perifosine (2.5 µg/ml) significantly increased the percentage of annexin-V-binding cells, significantly decreased average forward scatter, significantly increased the percentage of shrunken erythrocytes, and significantly decreased the percentage of swollen erythrocytes. Perifosine significantly increased the percentage of hemolytic erythrocytes. Perifosine significantly increased Fluo3-fluorescence, but decreased DCFDA fluorescence and ceramide abundance. The effect of perifosine on annexin-V-binding was significantly blunted by removal of extracellular Ca 2+ and by addition of staurosporine (1 µM), but not by addition of SB203580 (2 µM). Conclusions: Perifosine triggers eryptosis, an effect at least in part due to Ca 2+ entry and activation of staurosporine sensitive kinases.
Introduction
Perifosine, an alkylphospholipid drug [1, 2] , is effective against malignancy [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Mechanisms involved in the action of perifosine include interference with the activation of ] i ) [25] , ceramide [27] , caspases [25, 28, 29] , casein kinase 1α [25] , Janusactivated kinase JAK3 [25] , protein kinase C [25] , and p38 kinase [25] . Eryptosis is inhibited by PAK2 kinase [25] , AMP activated kinase AMPK [25] , cGMP-dependent protein kinase [25] , and sorafenib/sunitinib sensitive kinases [25] . Triggers of eryptosis include hyperosmotic shock [25] , oxidative stress [25] , energy depletion [25] , and a myriad of xenobiotics [25, .
The present study explored, whether perifosine may stimulate eryptosis. To this end, human erythrocytes from healthy volunteers were treated with perifosine and phosphatidylserine surface abundance, cell volume, [Ca 2+ ] i , reactive oxygen species (ROS) formation, and ceramide abundance determined by flow cytometry.
Materials and Methods

Erythrocytes, solutions and chemicals
Fresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 g for 20 min at 21 °C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 CaCl 2 , at 37°C for 24 hours. Where indicated, erythrocytes were exposed for 24 hours to perifosine (Sigma, Schnelldorf, Germany). In order to estimate the impact of Ca 2+ entry on perifosine induced eryptosis, erythrocytes were exposed to perifosine in the absence of extracellular Ca 2+ and presence of Ca 2+ chelator EGTA (1 mM, Merck Millipore, Darmstadt, Germany). To test for an involvement of kinases, erythrocytes were exposed for 24 hours to a combination of perifosine and p38 kinase inhibitor SB203580 (Tocris bioscience, Bristol, UK) or protein kinase C inhibitor staurosporine (Enzo Life Sciences, Lörrach, Germany).
Annexin-V-binding and forward scatter
After incubation under the respective experimental condition, a 100 µl cell suspension was washed in Ringer solution containing 5 mM CaCl 2 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, Friesoythe, Germany) in this solution at 37°C for 20 min under protection from light. The annexin-Vabundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, Germany). Annexin-V-binding was measured with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. A marker (M1) was placed to set an arbitrary threshold between annexin-V-binding cells and control cells. The same threshold was used for untreated and perifosine treated erythrocytes. A dot plot of forward scatter (FSC) vs. side scatter (SSC) was set to linear scale for both parameters. The threshold of forward scatter was set at the default value of "52". 
Intracellular Ca
Reactive oxidant species (ROS)
Oxidative stress was determined utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA). After incubation, a 200 µl suspension of erythrocytes was washed in Ringer solution and stained with DCFDA (Sigma, Schnelldorf, Germany) in Ringer solution containing DCFDA at a final concentration of 10 µM. Erythrocytes were incubated at 37°C for 30 min in the dark and washed two times in Ringer solution. The DCFDA-loaded erythrocytes were resuspended in 200 µl Ringer solution and ROS-dependent fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD). Subsequently, the geomean of the DCFDA dependent fluorescence was determined.
Ceramide abundance
For the determination of ceramide, a monoclonal antibody-based assay was used. To this end, cells were stained for 1 hour at 37°C with 1 µg/ml anti ceramide antibody (clone MID 15B4, Alexis, Grünberg, Germany) in PBS containing 0.1% bovine serum albumin (BSA) at a dilution of 1:10. The samples were washed twice with PBS-BSA. The cells were stained for 30 minutes with polyclonal fluorescein isothiocyanate (FITC) conjugated goat anti-mouse IgG and IgM specific antibody (Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. Unbound secondary antibody was removed by repeated washing with PBS-BSA. The samples were analyzed by flow cytometric analysis with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. Finally, the geomean of the ceramide-dependent fluorescence was determined.
Hemolysis
Following incubation, the erythrocyte suspension was centrifuged for 3 min at 1600 rpm, 4°C, and the supernatant harvested. As a measure of hemolysis, the hemoglobin (Hb) concentration in the supernatant was determined photometrically at 405 nm. The absorption of the supernatant of erythrocytes lysed in distilled water was defined as 100% hemolysis.
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis was made using ANOVA with Tukey's test as post-test and t test as appropriate. n denotes the number of different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control and experimental conditions.
Results
The present study explored, whether the alkylphospholipid drug perifosine stimulates eryptosis, the suicidal erythrocyte death. Hallmarks of eryptosis are phospholipid scrambling of the cell membrane and erythrocyte shrinkage.
Cell membrane scrambling was apparent from phosphatidylserine translocation to the erythrocyte surface which was visualized utilizing annexin-V-binding to phosphatidylserine, as determined by flow cytometry. Prior to determination of annexin-V-binding, the erythrocytes were incubated for 24 hours in Ringer solution without or with perifosine (0.25 -2.5 µg/ml). As illustrated in Fig. 1 , a 24 hours exposure to perifosine increased the percentage of phosphatidylserine exposing erythrocytes, an effect reaching statistical significance at 2.5 µg/ml perifosine.
Erythrocyte shrinkage was evidenced by measuring erythrocyte forward scatter utilizing flow cytometry. The measurements were performed after incubation for 24 hours in Ringer solution without or with perifosine (0.25 -2.5 µg/ml). As a result, exposure to perifosine decreased the average erythrocyte forward scatter, an effect reaching statistical significance at 2.5 µg/ml perifosine ( Fig. 2A,B) . Moreover, perifosine increased the percentage of shrunken erythrocytes (Fig. 2C ) and decreased the perentage of swollen erythrocytes (Fig.  2D) , effects reaching again statistical significance at 2.5 µg/ml perifosine. The observations revealed that perifosine did induce eryptosis. 
Cellular Physiology and Biochemistry
The stimulation of eryptosis was paralleled by stimulation of hemolysis. As illustrated in Fig. 3 , a 24 hours exposure to perifosine increased the percentage of hemolytic erythrocytes, an effect reaching statistical significance at 0.5 µg/ml perifosine.
Eryptosis could be triggered by increase of cytosolic Ca 2+ activity ([Ca   2+ ] i ). Fluo3 fluorescence was employed in order to quantify [Ca 2+ ] i . The erythrocytes were analyzed after a 24 hours incubation in Ringer solution without or with perifosine (0.25 -2.5 µg/ml). As illustrated in Fig. 4 , a 24 hours exposure to perifosine increased the Fluo3 fluorescence, an effect reaching statistical significance at 2.5 µg/ml perifosine. To explore, whether the effects of perifosine involved kinase activity, the influence of perifosine on annexin-V-binding was tested in the presence of p38 kinase inhibitor SB203580, or of protein kinase C inhibitor staurosporine. As illustrated in Fig. 6 , staurosporine (1 µM) significantly blunted the effect of perifosine on annexin-V-binding. However, even in the presence of staurosporine, perifosine significantly increased the percentage of annexin-Vbinding erythrocytes. Accordingly, perifosine-induced cell membrane scrambling was in part but not fully dependent on staurosporine sensitive kinases. As further illustrated in Fig.  6 , SB203580 (2 µM) tended to blunt the perifosine-induced annexin-V-binding, an effect, however, not reaching statistical significance.
Eryptosis is further stimulated by oxidative stress [25] . Reactive oxygen species (ROS) was thus quantified utilizing 2′,7′-dichlorodihydrofluorescein diacetate (DCFDA). As illustrated in Fig. 7 , a 24 hours exposure to perifosine (2.5 µg/ml) significantly decreased the DCFDA fluorescence of erythrocytes. Thus, perifosine rather decreased oxidative stress. A further stimulator of eryptosis is ceramide [25] . Ceramide abundance at the erythrocyte surface was thus quantified utilizing specific antibodies. As shown in Fig. 8, a 24 hours exposure to perifosine (2.5 µg/ml) significantly decreased the ceramide abundance at the erythrocyte surface. with (black bar) perifosine (2.5 µg/ml). **(p<0.01) indicates significant difference from the absence of perifosine (unpaired t test).
(black bar) perifosine (2.5 µg/ml). **(p<0.01) indicates significant difference from the absence of perifosine (unpaired t test).
Discussion
The present observations disclose a novel effect of the cytostatic drug perifosine, i.e. the triggering of erythrocyte shrinkage and stimulation of cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. Erythrocyte shrinkage and cell membrane scrambling are the hallmarks of eryptosis, the suicidal erythrocyte death [25] . The perifosine concentrations required for the stimulation of eryptosis are slightly higher than the concentrations (0.6 µg/ml) reported in the plasma of patients under perifosine treatment [82] . It must be kept in mind that the experiments have been performed with erythrocytes from healthy individuals. The susceptibility to undergo eryptosis is enhanced in diverse clinical conditions, including iron deficiency [25] , dehydration [83] , hyperphosphatemia [84] , chronic kidney disease (CKD) [85] [86] [87] [88] , hemolytic-uremic syndrome [89] , diabetes [90] , hepatic failure [30] , malignancy [25] , sepsis [91] , fever [25] , malaria [25] , sickle-cell disease [25] , beta-thalassemia [25] , Hb-C and G6PD-deficiency [25] , as well as Wilsons disease [91] . The stimulation of eryptosis may thus well explain the anemia following perifosine treatment.
The effect of perifosine on cell membrane scrambling was paralleled by an increase of cytosolic Ca 2+ activity ([Ca   2+ ] i ) and was significantly blunted by removal of extracellular Ca 2+ . Thus, perifosine-induced eryptosis was apparently in part dependent on Ca 2+ entry from the extracellular space. However, perifosine triggered cell membrane scrambling even in the nominal absence of extracellular Ca
2+
, an observation suggesting the involvement of additional mechanisms contributing to perifosine induced cell membrane scrambling. The erythrocytes are sensitized to the scrambling effect of Ca 2+ by ceramide [25] . However, perifosine rather decreased ceramide abundance. Perifosine further significantly decreased the abundance of reactive oxygen species, a well known stimulator of eryptosis [25] . Thus, perifosine was not effective by inducing oxidative stress. The effect of perifosine was not significantly blunted in the presence of p38 kinase blocker SB203580, but was significantly blunted in the presence of staurosporine. Thus, staurosporine sensitive kinases but not p38 kinase may be required for the full effect of perifosine on eryptosis. Both, SB203580 and staurosporine sensitive kinases are known to participate in the orchestration of eryptosis by other stimuli [25] .
The effect of perifosine on erythrocyte shrinkage is presumably at least in part secondary to increase of [Ca 2+ ] i with subsequent activation of Ca 2+ sensitive K + channels, K + exit, cell membrane hyperpolarization, Cl -exit and thus cellular loss of KCl with water [25] . Eryptotic erythrocytes are rapidly cleared from circulating blood by uptake into phagocytes [25] . The clearance of defective erythrocytes from circulating blood by eryptosis may precede hemolysis and thus accomplish clearance of defective erythrocytes prior to hemolysis [25] . Perifosine treatment is followed by hemolysis pointing to disruption of the cell membrane integrity. In vitro, the defective erythrocytes cannot be engulfed by phagocytes and thus not be removed. In vivo, hemolysis leads to release of hemoglobin which may pass the renal glomerular filter, precipitate in the acidic lumen of renal tubules, occlude nephrons and may thus lead to renal failure [92] .
The clearance of defective erythrocytes following eryptosis or hemolysis is expected to trigger anemia as soon as the loss of erythrocytes surpasses the formation of new erythrocytes by erythropoiesis [25] . Phosphatidylserine exposing erythrocytes further adhere to the vascular wall [93] , stimulate blood clotting and trigger thrombosis [94] [95] [96] , and may thus interfere with microcirculation [27, 94, [97] [98] [99] [100] .
In conclusion, perifosine triggers erythrocyte cell membrane scrambling, an effect involving Ca 2+ entry and activation of staurosporine sensitive kinases.
